loader
Please Wait
Applying Filters...
menu
    • menu

    Setid F2f20b37 8bd4 4e8a B596 Be80b48ca2f1 Applno 20571 Form Injectable Injection Dosage 100mg 5ml 20mg Ml - Drug Product Composition: 042LAQ1IIS

    Menu

    042LAQ1IIS

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 22,133Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 20571 / DOSAGE - INJECTABLE;INJECTION - 100MG/5ML (20MG/ML)

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    IRINOTECAN HYDROCHLORIDE(UNII: 042LAQ1IIS)
    (IRINOTECAN - UNII:7673326042)     		IRINOTECAN HYDROCHLORIDE20mg in 1

    Inactive Ingredients

    Ingredient Name
    Actavis Pharma, Inc.
    Armas Pharmaceuticals Inc.
    Fresenius Kabi USA, LLC
    Heritage Pharmaceuticals Inc.
    Pharmacia and Upjohn Company LLC
    Sagent Pharmaceuticals
    Sandoz Inc
    Sun Pharma Global FZE
    Teva Parenteral Medicines, Inc.
    Areva Pharmaceuticals,Inc.
    Cipla Limited
    NorthStar RxLLC
    BluePoint Laboratories
    HYDROCHLORIC ACID(QTT17582CB)    
    LACTIC ACID(33X04XA5AT)   
    LACTIC ACID, UNSPECIFIED FORM(33X04XA5AT)          
    SODIUM HYDROXIDE(55X04QC32I)
    SORBITOL(506T60A25R) 
    WATER(059QF0KO0R)